Literature DB >> 9476513

Prevalence of serotype D in Cryptococcus neoformans isolates from HIV positive and HIV negative patients in Italy.

A M Tortorano1, M A Viviani, A L Rigoni, M Cogliati, A Roverselli, A Pagano.   

Abstract

Cryptococcus neoformans strains isolated from 207 HIV positive and HIV negative patients hospitalized in Northern Italy were serotyped by slide agglutination. One Brazilian HIV negative woman was infected by var. gattii serotype B and all the other patients by var. neoformans, serotype D in 71%, serotype A in 24.6% and serotype AD in 3.4%. No difference was observed between subjects with serotypes A and D in HIV coinfection, exposure categories for AIDS, age, sex, and CD4 count of HIV positive patients. Meningeal and respiratory tract involvements and prostatic reservoir occurred with comparable frequency in AIDS patients infected by serotypes A and D. Skin lesions were observed only in serotype D infections, occurring in 12.6% of HIV positive and 58.3% of HIV negative patients infected by this serotype. Serotype A was found less susceptible to fluconazole than serotype D: 53.7% of serotype A strains had a MIC > or = 25 micrograms ml-1 compared to 17.7% of the serotype D isolates. On the other hand, both serotypes were highly susceptible to itraconazole.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9476513     DOI: 10.1111/j.1439-0507.1997.tb00235.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  17 in total

1.  Cryptococcus neoformans/Cryptococcus gattii species complex in southern Italy: an overview on the environmental diffusion of serotypes, genotypes and mating-types.

Authors:  Orazio Romeo; Fabio Scordino; Valeria Chillemi; Giuseppe Criseo
Journal:  Mycopathologia       Date:  2012-04-25       Impact factor: 2.574

2.  Extensive genetic diversity within the Dutch clinical Cryptococcus neoformans population.

Authors:  Ferry Hagen; María-Teresa Illnait-Zaragozí; Jacques F Meis; William H M Chew; Ilse Curfs-Breuker; Johan W Mouton; Andy I M Hoepelman; Lodewijk Spanjaard; Paul E Verweij; Greetje A Kampinga; Ed J Kuijper; Teun Boekhout; Corné H W Klaassen
Journal:  J Clin Microbiol       Date:  2012-03-21       Impact factor: 5.948

3.  Serotype sensitivity of a lateral flow immunoassay for cryptococcal antigen.

Authors:  Marcellene A Gates-Hollingsworth; Thomas R Kozel
Journal:  Clin Vaccine Immunol       Date:  2013-01-30

4.  Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.

Authors:  E Dannaoui; M Abdul; M Arpin; A Michel-Nguyen; M A Piens; A Favel; O Lortholary; F Dromer
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

5.  Cryptococcosis in AIDS.

Authors:  P Imwidthaya; N Poungvarin
Journal:  Postgrad Med J       Date:  2000-02       Impact factor: 2.401

6.  Prevalence of Cryptococcus neoformans var. neoformans (Serotype D) and Cryptococcus neoformans var. grubii (Serotype A) isolates in New York City.

Authors:  J N Steenbergen; A Casadevall
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

7.  Serotyping of Cryptococcus neoformans isolates from clinical and environmental sources in Spain.

Authors:  T Baró; J M Torres-Rodríguez; Y Morera; C Alía; O López; R Méndez
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

8.  Molecular typing of IberoAmerican Cryptococcus neoformans isolates.

Authors:  Wieland Meyer; Alexandra Castañeda; Stuart Jackson; Matthew Huynh; Elizabeth Castañeda
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

9.  Cryptococcus neoformans, Cryptococcus gattii: serotypes in Venezuela.

Authors:  C Pérez; M Dolande; M Moya; A Roselló; Claudia R Hartung de Capriles; M E Landaeta; S Mata-Essayag
Journal:  Mycopathologia       Date:  2008-05-30       Impact factor: 2.574

10.  Cryptococcus neoformans meningoencephalitis in a patient with polyarteritis nodosa.

Authors:  Vladimír Buchta; Petr Prášil; Marcela Vejsová; Roman Mottl; Radka Kutová; Marcela Drahošová; Stanislav Plíšek
Journal:  Folia Microbiol (Praha)       Date:  2014-06-20       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.